Bionime will offer innovative GE-branded clinical and home-based patient care products for the rapidly growing global diabetes population ALBANY, N.Y. & MILWAUKEE--(BUSINESS WIRE)-- GE (NYSE: GE) ...
Biomedical engineers have created a biopolymer that can provide weeks of glucose control with a single injection. The new tool has the potential to replace daily or weekly insulin shots with bi-weekly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results